Amvia Biotech

Amvia Biotech is a biotechnology company specializing in regenerative medicine and the development of exosome-based therapies. Based in Mexico, the company focuses on the isolation and characterization of exosomes derived from mesenchymal stem cells (MSCs) to treat inflammatory, orthopedic, and dermatological conditions. Their proprietary platform ensures high purity and concentration of bioactive molecules, offering a cell-free alternative to traditional stem cell treatments. Amvia Biotech provides products for both clinical research and aesthetic applications, aiming to advance the field of regenerative medicine through standardized, scalable biological solutions.